Mundipharma expands its European footprint with Herceptin biosimilar 04-Jul-2019 By Vassia Barba Mundipharma partners with Prestige to commercialize and supply a biosimilar to Roche’s Herceptin, for patients with breast, gastric and gastroesophageal cancer.